UBE2T Promotes Temozolomide Resistance of Glioblastoma Through Regulating the Wnt/β-Catenin Signaling Pathway
Yang Wang, Ge Gao, Xiangpin Wei, Yang Zhang, Jian Yu Department of Neurosurgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People’s Republic of ChinaCorrespondence: Jian Yu, Department of Neurosurgery, The Fir...
| Published in: | Drug Design, Development and Therapy |
|---|---|
| Main Authors: | Wang Y, Gao G, Wei X, Zhang Y, Yu J |
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2023-05-01
|
| Subjects: | |
| Online Access: | https://www.dovepress.com/ube2t-promotes-temozolomide-resistance-of-glioblastoma-through-regulat-peer-reviewed-fulltext-article-DDDT |
Similar Items
Targeting Wnt/β-catenin activation in combination with temozolomide leads to glioblastoma inhibition and long-term survival in mice
by: Xiaowei Zhang, et al.
Published: (2026-01-01)
by: Xiaowei Zhang, et al.
Published: (2026-01-01)
UBE2S promotes the progression and Olaparib resistance of ovarian cancer through Wnt/β-catenin signaling pathway
by: Wenjing Hu, et al.
Published: (2021-09-01)
by: Wenjing Hu, et al.
Published: (2021-09-01)
Lichen Secondary Metabolites Inhibit the Wnt/β-Catenin Pathway in Glioblastoma Cells and Improve the Anticancer Effects of Temozolomide
by: Aleksandra Majchrzak-Celińska, et al.
Published: (2022-03-01)
by: Aleksandra Majchrzak-Celińska, et al.
Published: (2022-03-01)
Oncogenic UBE3C promotes breast cancer progression by activating Wnt/β-catenin signaling
by: Chen Hang, et al.
Published: (2021-01-01)
by: Chen Hang, et al.
Published: (2021-01-01)
Platycodin D Enhances Glioma Sensitivity to Temozolomide by Inhibition of the Wnt/β-Catenin Pathway
by: Li H, et al.
Published: (2025-03-01)
by: Li H, et al.
Published: (2025-03-01)
Wnt-signaling pathway in pathogenesis of glioblastoma multiforme
by: Yu. D. Vasilets, et al.
Published: (2019-01-01)
by: Yu. D. Vasilets, et al.
Published: (2019-01-01)
Transcription factor YY1-activated GNG5 facilitates glioblastoma cell growth, invasion, stemness and glycolysis through Wnt/β-catenin pathway
by: Sheng Liang, et al.
Published: (2024-10-01)
by: Sheng Liang, et al.
Published: (2024-10-01)
Evodiamine Exerts Anticancer Effects Against 143B and MG63 Cells Through the Wnt/β-Catenin Signaling Pathway
by: Yang S, et al.
Published: (2020-04-01)
by: Yang S, et al.
Published: (2020-04-01)
UBE2N promotes cell viability and glycolysis by promoting Axin1 ubiquitination in prostate cancer cells
by: Bo Yang, et al.
Published: (2024-05-01)
by: Bo Yang, et al.
Published: (2024-05-01)
High expression of LncRNA HOTAIR is a risk factor for temozolomide resistance in glioblastoma via activation of the miR-214/β-catenin/MGMT pathway
by: Tian Lan, et al.
Published: (2024-10-01)
by: Tian Lan, et al.
Published: (2024-10-01)
Commentary: Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy?
by: Christine A. Fargeas, et al.
Published: (2021-08-01)
by: Christine A. Fargeas, et al.
Published: (2021-08-01)
The Dual Role and Therapeutic Implications of the Wnt/β-Catenin Pathway in Diabetic Kidney Disease
by: Adeerjiang Y, et al.
Published: (2025-05-01)
by: Adeerjiang Y, et al.
Published: (2025-05-01)
Wnt/beta-catenin pathway: modulating anticancer immune response
by: Sachin Gopalkrishna Pai, et al.
Published: (2017-05-01)
by: Sachin Gopalkrishna Pai, et al.
Published: (2017-05-01)
New Advances in Canonical Wnt/β-Catenin Signaling in Cancer
by: Wen X, et al.
Published: (2020-08-01)
by: Wen X, et al.
Published: (2020-08-01)
Neuropilin-2 Mediates Radioresistance in Nasopharyngeal Carcinoma via Wnt/β-Catenin Pathway
by: Chen J, et al.
Published: (2025-09-01)
by: Chen J, et al.
Published: (2025-09-01)
Sevoflurane inhibits cholangiocarcinoma via Wnt/β-catenin signaling pathway
by: Hui Cheng, et al.
Published: (2023-08-01)
by: Hui Cheng, et al.
Published: (2023-08-01)
AhR and Wnt/β-Catenin Signaling Pathways and Their Interplay
by: Alevtina Y. Grishanova, et al.
Published: (2023-05-01)
by: Alevtina Y. Grishanova, et al.
Published: (2023-05-01)
Hyperin Controls the Development and Therapy of Gastric Cancer via Regulating Wnt/β-Catenin Signaling
by: Ping MH
Published: (2020-11-01)
by: Ping MH
Published: (2020-11-01)
LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway
by: Wenchan Hsu, et al.
Published: (2019-06-01)
by: Wenchan Hsu, et al.
Published: (2019-06-01)
Opposed Interplay between IDH1 Mutations and the WNT/β-Catenin Pathway: Added Information for Glioma Classification
by: Alexandre Vallée, et al.
Published: (2021-05-01)
by: Alexandre Vallée, et al.
Published: (2021-05-01)
Zinc promotes cell apoptosis via activating the Wnt-3a/β-catenin signaling pathway in osteosarcoma
by: Kai Gao, et al.
Published: (2020-02-01)
by: Kai Gao, et al.
Published: (2020-02-01)
Long Noncoding RNA LINC-PINT Suppresses Cell Proliferation, Invasion, and EMT by Blocking Wnt/β-Catenin Signaling in Glioblastoma
by: Hanshuo Zhu, et al.
Published: (2021-01-01)
by: Hanshuo Zhu, et al.
Published: (2021-01-01)
Importance of Autophagy Regulation in Glioblastoma with Temozolomide Resistance
by: Young Keun Hwang, et al.
Published: (2024-08-01)
by: Young Keun Hwang, et al.
Published: (2024-08-01)
The expression of pro-prion, a transmembrane isoform of the prion protein, leads to the constitutive activation of the canonical Wnt/β-catenin pathway to sustain the stem-like phenotype of human glioblastoma cells
by: Alessandro Corsaro, et al.
Published: (2024-12-01)
by: Alessandro Corsaro, et al.
Published: (2024-12-01)
Overview of Wnt/β-Catenin Pathway and DNA Damage/Repair in Cancer
by: Silvina B. Nadin, et al.
Published: (2025-02-01)
by: Silvina B. Nadin, et al.
Published: (2025-02-01)
Expression study of Wnt/β-catenin signaling pathway associated lncRNAs in schizophrenia
by: Fatemeh Manafzadeh, et al.
Published: (2025-01-01)
by: Fatemeh Manafzadeh, et al.
Published: (2025-01-01)
Integrins and p53 pathways in glioblastoma resistance to temozolomide
by: Monique eDontenwill, et al.
Published: (2012-10-01)
by: Monique eDontenwill, et al.
Published: (2012-10-01)
Relationship between Wnt/β-catenin signaling pathway and lupus nephritis
by: MA Xiao, et al.
Published: (2018-01-01)
by: MA Xiao, et al.
Published: (2018-01-01)
Temozolomide Resistance in Glioblastoma by NRF2: Protecting the Evil
by: Karoline Almeida Lima, et al.
Published: (2023-04-01)
by: Karoline Almeida Lima, et al.
Published: (2023-04-01)
CRABP2 Promotes the Proliferation of Dermal Papilla Cells via the Wnt/β-Catenin Pathway
by: Mingliang He, et al.
Published: (2023-06-01)
by: Mingliang He, et al.
Published: (2023-06-01)
The recent progress of peptide regulators for the Wnt/β-catenin signaling pathway
by: Nan Zhang, et al.
Published: (2023-06-01)
by: Nan Zhang, et al.
Published: (2023-06-01)
Activating Transcription Factor 5 Promotes Tumorigenic Capability in Cervical Cancer Through the Wnt/β-Catenin Signaling Pathway
by: Shi F, et al.
Published: (2025-01-01)
by: Shi F, et al.
Published: (2025-01-01)
TTK Protein Kinase promotes temozolomide resistance through inducing autophagy in glioblastoma
by: Jian Yu, et al.
Published: (2022-07-01)
by: Jian Yu, et al.
Published: (2022-07-01)
Ionizing Radiation Induces Resistant Glioblastoma Stem-Like Cells by Promoting Autophagy via the Wnt/β-Catenin Pathway
by: Cheng-Yu Tsai, et al.
Published: (2021-05-01)
by: Cheng-Yu Tsai, et al.
Published: (2021-05-01)
Cinnamaldehyde Inhibits the Function of Osteosarcoma by Suppressing the Wnt/β-Catenin and PI3K/Akt Signaling Pathways [Retraction]
by: Huang Y, et al.
Published: (2024-04-01)
by: Huang Y, et al.
Published: (2024-04-01)
CDCP1 promotes the malignant phenotypes of nasopharyngeal carcinoma via the Wnt/β-catenin signaling pathway
by: Guoliang Bie, et al.
Published: (2025-07-01)
by: Guoliang Bie, et al.
Published: (2025-07-01)
The Wnt/β-catenin signaling pathway in the tumor microenvironment of hepatocellular carcinoma
by: Kaiting Wang, et al.
Published: (2022-03-01)
by: Kaiting Wang, et al.
Published: (2022-03-01)
Quinacrine enhances temozolomide cytotoxicity in temozolomide-sensitive and -resistant glioblastoma cells
by: Pingde Zhang, et al.
Published: (2018-01-01)
by: Pingde Zhang, et al.
Published: (2018-01-01)
Thymol Isolated from Thymus vulgaris L. Inhibits Colorectal Cancer Cell Growth and Metastasis by Suppressing the Wnt/β-Catenin Pathway
by: Zeng Q, et al.
Published: (2020-07-01)
by: Zeng Q, et al.
Published: (2020-07-01)
SOX9 Inhibits the Progression of Osteonecrosis of the Femoral Head via the Activation of the Wnt/Beta-Catenin Pathway
by: Xiangsheng Meng, et al.
Published: (2023-12-01)
by: Xiangsheng Meng, et al.
Published: (2023-12-01)
Similar Items
-
Targeting Wnt/β-catenin activation in combination with temozolomide leads to glioblastoma inhibition and long-term survival in mice
by: Xiaowei Zhang, et al.
Published: (2026-01-01) -
UBE2S promotes the progression and Olaparib resistance of ovarian cancer through Wnt/β-catenin signaling pathway
by: Wenjing Hu, et al.
Published: (2021-09-01) -
Lichen Secondary Metabolites Inhibit the Wnt/β-Catenin Pathway in Glioblastoma Cells and Improve the Anticancer Effects of Temozolomide
by: Aleksandra Majchrzak-Celińska, et al.
Published: (2022-03-01) -
Oncogenic UBE3C promotes breast cancer progression by activating Wnt/β-catenin signaling
by: Chen Hang, et al.
Published: (2021-01-01) -
Platycodin D Enhances Glioma Sensitivity to Temozolomide by Inhibition of the Wnt/β-Catenin Pathway
by: Li H, et al.
Published: (2025-03-01)
